Enfusion, Inc.

NYSE:ENFN

8.72 (USD) • At close November 4, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q1
Revenue 49.45548.05246.48644.35742.72140.97140.51739.15136.5434.14131.85329.04526.44924.35322.6619.78518.5618.56
Cost of Revenue 15.96216.17415.62414.50714.20813.30213.29611.97410.84710.98310.1648.0956.7776.8096.1585.3934.9044.904
Gross Profit 33.49331.87830.86229.8528.51327.66927.22127.17725.69323.15821.68920.9519.67217.54416.50214.39213.65713.657
Gross Profit Ratio 0.6770.6630.6640.6730.6670.6750.6720.6940.7030.6780.6810.7210.7440.720.7280.7270.7360.736
Reseach & Development Expenses 6.0966.5516.0614.9374.4644.4314.7753.8643.7224.802146.5562.62.0412.2021.7971.6421.441.44
General & Administrative Expenses 18.67320.22317.11516.72116.32614.47315.07313.09418.30222.295128.2298.5467.4576.38123.3144.5094.0324.032
Selling & Marketing Expenses 6.0216.2175.5525.5035.2774.0866.0017.2787.5758.43239.4024.9014.2643.1583.3122.0682.2742.274
SG&A 24.69426.4422.66722.22421.60318.55921.07420.37225.87730.727167.63113.44711.7219.53926.6266.5776.3066.306
Other Expenses -0.111-0.082-1.6730.417-1.260.411-0.59-0.0520.0010.003-1.2140.029000.081000
Operating Expenses 30.7932.99128.72827.16126.06722.9925.84924.23629.59935.529314.18716.04713.76211.74128.4238.2197.7447.744
Operating Income 2.703-1.1132.1342.6892.4464.6791.3722.941-3.906-12.371-292.4984.9035.915.803-11.9216.1735.9115.911
Operating Income Ratio 0.055-0.0230.0460.0610.0570.1140.0340.075-0.107-0.362-9.1830.1690.2230.238-0.5260.3120.3180.318
Total Other Income Expenses Net 0.2450.2350.0460.339-1.260.411-0.166-0.0560.001-0.003-1.2140.029-1.41-1.3920.081-0.365-0.363-0.363
Income Before Tax 2.948-0.8782.183.0281.1865.091.2062.885-3.906-12.374-294.0193.4474.54.411-12.415.8085.5485.548
Income Before Tax Ratio 0.06-0.0180.0470.0680.0280.1240.030.074-0.107-0.362-9.230.1190.170.181-0.5480.2940.2990.299
Income Tax Expense 0.401-0.1171.280.3670.1880.3960.4180.2870.2190.15-0.1250.1540.2490.302-0.2230.2280.2150.215
Net Income 1.826-0.5390.6231.8280.6294.6940.7882.598-2.422-12.524-293.8943.2934.2514.109-12.1875.585.3345.334
Net Income Ratio 0.037-0.0110.0130.0410.0150.1150.0190.066-0.066-0.367-9.2270.1130.1610.169-0.5380.2820.2870.287
EPS 0.02-0.0060.0070.0210.0070.0530.0090.02-0.029-0.16-3.530.0510.0660.064-0.190.0870.0830.06
EPS Diluted 0.014-0.0060.0050.0140.0050.0360.0060.02-0.029-0.15-3.530.0510.0660.064-0.190.0870.0830.06
EBITDA 5.5761.5614.2495.2894.5286.5473.114.588-3.905-11.028-292.3965.9196.8276.558-11.176.7836.2546.254
EBITDA Ratio 0.1130.0320.0910.1190.1060.160.0770.117-0.107-0.323-9.180.2040.2580.269-0.4930.3430.3370.337